Heterogeneity of Lipopolysaccharide as Source of Variability in Bioassays and LPS-Binding Proteins as Remedy
Open accessThe DOI matches its Crossref record; 227 of the 228 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Lipopolysaccharide (LPS), also referred to as endotoxin, is the major component of Gram-negative bacteria’s outer cell wall. It is one of the main types of pathogen-associated molecular patterns (PAMPs) that are known to elicit severe immune reactions in the event of a pathogen trespassing the epithelial barrier and reaching the bloodstream. Associated symptoms include fever and septic shock, which in severe cases, might even lead to death. Thus, the detection of LPS in medical devices and injectable pharmaceuticals is of utmost importance. However, the term LPS does not describe one single molecule but a diverse class of molecules sharing one common feature: their characteristic chemical structure. Each bacterial species has its own pool of LPS molecules varying in their chemical composition and enabling the aggregation into different supramolecular structures upon release from the bacterial cell wall. As this heterogeneity has consequences for bioassays, we aim to examine the great variability of LPS molecules and their potential to form various supramolecular structures. Furthermore, we describe current LPS quantification methods and the LPS-dependent inflammatory pathway and show how LPS heterogeneity can affect them. With the intent of overcoming these challenges and moving towards a universal approach for targeting LPS, we review current studies concerning LPS-specific binders. Finally, we give perspectives for LPS research and the use of LPS-binding molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, bacteria can present diverse variations of the LPS molecule, each with distinct chemical, structural, and functional heterogeneity and varying immunogenicity (Fig. 3e).134”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Lactosmart: A Novel Therapeutic Molecule for Antimicrobial Defense
Singh, J., Viswanathan, V., Ahmedi, S., Pant, P., Manzoor, N., Singh, T. P., Sharma, P., & Sharma, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.672589 · Cited by 10 · cited 3×
“Origin Binding Molecule LPS Strain (Serotype) LPS Target KD Values Citation Human MD-2 E. coli (O55:B5) Lipid A 3.2 µM [185] Human TLR4 E. coli (O55:B5) Lipid A 14.1 µM [185] Human LBP S.minnesota (Re595) Lipid A 3.5 nM [210] Human rLBP E. coli (J5) Lipid A 1.05 nM [211] Human 5I-histidine-rich polypeptide (Histatin 5…”
BackgroundInfluentialRetractedMeasurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482 · cited 1×
“Thus, it is recommended to quantify the protein content in LPS using a protein quantification method, such as the bicinchoninic acid assay [232].”
MethodDefective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631 · cited 1×
“The most relevant innate immune receptor activated by extracellular LPS is toll–like receptor 4 (TLR4), which was identified in the late 1990s [95,96].”
BackgroundRaetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404 · cited 2×
“KDO is part of the inner core region of LPS and is present in the majority of (G-) bacteria [14].”
BackgroundHoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233 · cited 1×
“TLR4 is mainly expressed on the surface of both immune cells—such as monocytes, macrophages, neutrophils, dendritic cells, and natural killer cells [97,98]—and somatic cells—including fibroblasts and epithelial cells [97,99].”
BackgroundThe structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
Park, B. S., Song, D. H., Kim, H. M., Choi, B.-S., Lee, H., & Lee, J.-O. (2009) · Nature · doi:10.1038/nature07830 · Cited by 2,428 · cited 1×
“The loaded MD-2 is then recognized by TLR4 promoting the assembly of a supramolecular TLR4-CD14-MD-2 receptor complex [100,101].”
BackgroundHotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J.-L. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.45 · Cited by 1,620
Bacterial endotoxin: molecular relationships of structure to activity and function
Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zähringer, U., Seydel, U., Di Padova, F., et al. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.2.8119492 · Cited by 1,607 · cited 1×
“5 kDa (R-form) to 70 kDa (S-forms with long O-antigens), being the average between 10 and 20 kDa [5,80,82].”
BackgroundLipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,340 · cited 1×
“Changing the overall molecular charge by the loss or addition of phosphate groups and/or the addition of positively charged sugar units can influence the resistance against cationic antimicrobial molecules [28,29].”
Background
Research works printed but not linked: 8
- Kolmos, 2006, Panum’s Studies on “Putrid Poison” 1856, Dan. Med. Bull., 53, 450
- Williams, K.L. (2019). Discovery and Early Development of the Limulus Test, Springer International Publishing.
- Loverock, 2010, A Recombinant Factor C Procedure for the Detection of Gram-Negative Bacterial Endotoxin, United States Pharmacop. Conv.-Pharmacop. Forum, 36, 321
- Dawson, 1993, Endotoxin Standards and CSE Potency, LAL Updat., 11, 1
- Tsuchiya, 2014, Possible Mechanism of Low Endotoxin Recovery, Am. Pharm. Rev., 17, 1
- Meadows, 2018, Aseptic Sampling Best Practices Endotoxin Binding Affinity, Sartorius, SP-4006-e, 1
- Novitsky, 1988, The Problems with Plastics, Lal Update, 6, 1
- (2023, February 12). PubMed Keyword “Endotoxin” 5203 Events, Keyword “Lipopolysaccharide” 7853 Events, Available online: https://pubmed.ncbi.nlm.nih.gov/.
Cited by
PAMPs and DAMPs in Sepsis: A Review of Their Molecular Features and Potential Clinical Implications
Cicchinelli, S., Pignataro, G., Gemma, S., Piccioni, A., Picozzi, D., Ojetti, V., Franceschi, F., & Candelli, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020962 · Cited by 155
“Recently, it has been highlighted that LPS may enter the cell via a clathrin-mediated endocytosis of outer membrane vesicles (OMVs), or through the preliminary extracellular binding to the HMGB1 protein, and subsequent conjunction with RAGE [45].”
BackgroundInfluentialLipopolysaccharide delivery systems in innate immunity
Liu, J., Kang, R., & Tang, D. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.02.003 · Cited by 112
Peregrino, E. S., Castañeda‐Casimiro, J., Vázquez-Flores, L., Estrada-Parra, S. A., Baeza, C. W., Serafín‐López, J., & Wong‐Baeza, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116210 · Cited by 70
Boronic acid-assisted detection of bacterial pathogens: Applications and perspectives
Gao, S., Zhang, Y., Zhou, R., Shen, T., Zhang, D., Guo, Z., & Zou, X. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216082 · Cited by 57
Michelini, S., Mawas, S., Kurešepi, E., Barbero, F., Šimunović, K., Miremont, D., Devineau, S., Schicht, M., Ganin, V. S., Haugen, Ø. P., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03419-6 · Cited by 40
“Thus, in this context, the use of this assay is particularly relevant as it more closely reflects the natural response of cells to endotoxins when compared, for example, to a standard limulus amoebocyte lysate assay (LAL) [37, 38].”
Self-citation
Metadata
- Authors
- Fux, A. C., Casonato Melo, C., Michelini, S., Swartzwelter, B. J., Neusch, A., Italiani, P., & Himly, M.
- Affiliations
- Miltenyi Biotec (Germany) (DE)
- Division of Allergy & Immunology, Department of Biosciences & Medical Biology, Paris Lodron University of Salzburg (PLUS), Hellbrunnerstraße 34, 5020 Salzburg, Austria
- University of Ljubljana (SI)
- Colorado State University (US)
- Heinrich Heine University Düsseldorf (DE)
- Stazione Zoologica Anton Dohrn (IT)
- University of Salzburg (AT)
- Corresponding author
- Himly, Martin
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-05-07
- Volume
- 24
- Issue
- 9
- Pages
- 8395
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10179214
- OpenAlex
- W4375862682
- Cited by
- 83
- References
- 225
- Citations by year
- 2026: 27 · 2025: 24 · 2024: 26 · 2023: 6
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository of the University of Ljubljana (University of Ljubljana) (submittedVersion, cc-by)
- Funders
- European Union’s Horizon 2020 research and innovation programme (H2020-MSCA-ITN-2018-812661, 890610)
- Austrian Research Promotion Agency (FFG) (H2020-MSCA-ITN-2018-812661, 890610)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- lipopolysaccharide, endotoxin, LPS-binding protein, Gram-negative bacteria, pathogen-associated molecular patterns, septic shock
- MeSH terms
- Biological Assay, Endotoxins, Humans, Lipopolysaccharides, Shock, Septic, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Heterogeneity of Lipopolysaccharide as Source of Variability in Bioassays and LPS-Binding Proteins as Remedy. https://app.cochat.ai/papers/10.3390/ijms24098395
- The paper
- Fux, A. C., Casonato Melo, C., Michelini, S., Swartzwelter, B. J., Neusch, A., Italiani, P., & Himly, M. (2023). Heterogeneity of Lipopolysaccharide as Source of Variability in Bioassays and LPS-Binding Proteins as Remedy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098395
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.